People | January 10, 2023
GenNext Technologies appoints Dr. John Grant to its Board of Directors
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
The new project further expands the partner's long-term collaboration on new technologies for R&D
A study by Agharkar Research Institute (ARI), Pune, has discovered that a protein secreted from intervertebral disc cells induces disc regeneration in aged degenerated discs
Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Seeks partnership between government and private medical colleges for providing superior medical education
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
BDRs journey for the treatment of Prostate Cancer started with Abiratarone Acetate, then Leuprolide Acetate followed by Enzalutamide and, then Degarelix and Triptorelin.
To create leading company developing medicines targeting metalloenzymes
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
Subscribe To Our Newsletter & Stay Updated
